Are natural products and medical diagnostic tests still eligible for patents in the USA?
{{output}}
In 2010, the biotechnology and molecular diagnostics industries were shocked by the decision from a US District Court to the effect that isolated endogenous DNA and diagnostic tests based on newly discovered DNA sequences were not eligible for US patents. The ... ...
